Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Caliway Biopharmaceuticals Co Ltd (6919) Financial Statements

Caliway Biopharmaceuticals Co Ltd Financial Overview

Caliway Biopharmaceuticals Co Ltd's market cap is currently NT$109.78B. The company's EPS TTM is NT$-0.16; its P/E ratio is -174.87; Caliway Biopharmaceuticals Co Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 37.98MNT$ 44.36MNT$ 38.88MNT$ 12.83MNT$ 12.32M
Gross ProfitNT$ 26.48MNT$ 1.25MNT$ 27.44MNT$ -15.74MNT$ 9.22M
Operating IncomeNT$ -706.09MNT$ -715.96MNT$ -512.84MNT$ -319.82MNT$ -230.43M
EBITDANT$ -675.43MNT$ -686.45MNT$ -484.97MNT$ -294.49MNT$ -207.15M
Net IncomeNT$ -351.35MNT$ -587.85MNT$ -487.85MNT$ -286.33MNT$ -224.00M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 154.87MNT$ 9.67BNT$ 3.71BNT$ 1.11BNT$ 594.12M
Total AssetsNT$ 301.89MNT$ 9.77BNT$ 3.83BNT$ 1.23BNT$ 711.96M
Total DebtNT$ 95.53KNT$ 11.87MNT$ 20.46MNT$ 28.68MNT$ 36.73M
Net DebtNT$ -24.90MNT$ -6.89BNT$ -3.40BNT$ -626.37MNT$ -557.39M
Total LiabilitiesNT$ 2.03MNT$ 73.69MNT$ 85.55MNT$ 68.82MNT$ 68.15M
Stockholders' EquityNT$ 299.86MNT$ 9.70BNT$ 3.74BNT$ 1.16BNT$ 643.81M
Cash Flow
Free Cash FlowNT$ -443.04MNT$ -533.40MNT$ -433.62MNT$ -256.93MNT$ -125.43M
Operating Cash FlowNT$ -425.90MNT$ -522.31MNT$ -423.94MNT$ -242.76MNT$ -110.55M
Investing Cash FlowNT$ -5.62BNT$ -2.49BNT$ 157.09MNT$ -470.54MNT$ -14.88M
Financing Cash FlowNT$ -119.11MNT$ 6.49BNT$ 3.03BNT$ 771.72MNT$ 625.98M

Currency in TWD

Caliway Biopharmaceuticals Co Ltd Earnings and Revenue History

-800M-400M0400M-2400 %-1600 %-800 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Caliway Biopharmaceuticals Co Ltd Liabilities to Assets

04B8B12B0 %40 %80 %120 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Caliway Biopharmaceuticals Co Ltd Cash Flow

-7.5B-5B-2.5B02.5B5B7.5B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Caliway Biopharmaceuticals Co Ltd Forecast EPS vs Actual EPS

-101234Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >